Scarborough Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-812
Closed -$97.7K 470
2026
Q1
$97.7K Buy
812
+45
+6% +$5.2K 0.01% 189
2025
Q4
$80.7K Sell
767
-3
-0.4% -$282 0.01% 116
2025
Q3
$64.6K Sell
770
-43
-5% -$3.54K 0.01% 124
2025
Q2
$64.4K Buy
+813
New +$64.6K 0.01% 123
2024
Q3
Sell
-606
Closed -$75K 320
2024
Q2
$75K Buy
606
+8
+1% +$1.03K 0.03% 81
2024
Q1
$78.9K Buy
598
+19
+3% +$2.34K 0.04% 75
2023
Q4
$63.1K Buy
+579
New +$60.1K 0.01% 149

Other funds holding MRK

Scarborough Advisors's MRK Position: Q2 2026 in Review

Scarborough Advisors sold out of Merck (MRK) in Q2 2026, closing a stake of 812 shares — an estimated $97.7K sold.

Scarborough Advisors first reported a position in MRK in Q4 2023 and held it in 7 quarters. The position peaked at $97.7K in Q1 2026. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Scarborough Advisors reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
  • Scarborough Advisors sold 812 Merck shares in Q2 2026, an estimated $97.7K.
  • Scarborough Advisors first reported a position in Merck in Q4 2023 and held it in 7 quarters.
  • Scarborough Advisors's Merck position peaked at $97.7K in Q1 2026.
  • 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Scarborough Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.